Modern Retina | Ophthalmology News, Events & Expert Insights
November 1st 2024. Alfredo Sadun, MD, PhD, is the chief of Ophthalmology at the Doheny Eye Institute of UCLA. At this year's AAO meeting held in Chicago, Illinois, he stopped by the Eye Care Network booth to share insights from the symposium "Professional Longevity 2.0: Assessing the Ophthalmologist," which he presented during.
Dealing with complications of silicone oil - Modern Retina
Sep 2, 2022 · Vision loss associated with a silicone oil endotamponade in vitreoretinal surgery is a rare yet underreported complication, but it is becoming increasingly important as technical refinements of the surgical procedure progress along with the increasing visual expectations of individual patients.
Distinction between lamellar holes and macular pseudoholes
Mar 12, 2018 · By Vanessa Caceres; Reviewed by John T. Thompson, MD. Continuity of the external limiting membrane (ELM)/ellipsoid layers can help to identify eyes with lamellar macular holes that are likely to benefit from surgery, according to John T. Thompson, MD.. Dr. Thompson of Retina Specialists, Baltimore, MD, addressed two types of partial thickness macular holes-lamellar macular holes and ...
EURETINA
Ali Erginay, MD, MD, spoke about the important developments in retinal imaging, specifically the Red-Blue-Green (RGB) imaging modalities during his interview with Ophthalmology Times Europe, which took place at the EURETINA 2024 meeting held in Barcelona, Spain, on September 19-22, 2024.
Latest Conference Articles - Modern Retina
In a paper presented at the American Academy of Ophthalmology annual meeting in Chicago, Jonathan Tan, a third year medical student at the Icahn School of Medicine at Mount Sinai detailed the study on ophthalmic eye drop waste in clinics, revealing 72% medication loss due to outdated 28-day expiration guidelines, resulting in significant financial waste.
jCyte, Inc. announces pivotal trial of jCell for RP to start in second ...
Feb 24, 2024 · jCyte, Inc. announced in a press release the positive pre-phase 3 FDA type B meeting that took place on January 16. The pivotal trial of jCell to treat retinitis pigmentosa (RP) is scheduled to start enrollment during the second half of 2024.
Achromatopsia: Understanding the rare inherited retinal disease
Aug 27, 2018 · Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Nanoscope Therapeutics lead candidate MCO-010 meets …
Mar 26, 2024 · MCO-010 demonstrated a statistically significant improvement of best-corrected visual acuity (BCVA) at week 52.
Angiogenesis 2024: Expanded efficacy data from the GATHER 2 trial
Feb 3, 2024 · Sydney M Crago, the editor of Modern Retina, talks with Arshad M Khanani, MD, MA, FASRS, about the expanded efficacy data from the GATHER 2 trial for geographic atrophy (GA).
ARVO - Modern Retina
At this year's ARVO meeting, Dolly Chang, MD, PhD, presented data on the early fluid reduction in patients with diabetic macular edema, and how that correlates with 1-year outcome with a deep learning-based retina segmentation tool using the Phase 2 BOULEVARD study.